Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Roberson

Showing results (151-160 of 203) with videos related to

Pageof 21
Sort By:
Cancer Causes & Control : CCC|November 16, 2021
Validity of breast cancer surgery treatment information in a state-based cancer registryMya L Roberson, Hazel B Nichols, Stephanie B Wheeler, et al.
Journal of the National Cancer Institute|January 2, 2025
An intersectional analysis of behavioral financial hardship and healthcare utilization among lesbian, gay, bisexual, transgender, queer, plus cancer survivorsAustin R Waters, Stephanie B Wheeler, Jeremey Fine, et al.
Frontiers in Public Health|August 4, 2018
Engaging Black Churches to Address Cancer Health Disparities: Project CHURCHLorna H McNeill, Lorraine R Reitzel, Kamisha H Escoto, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
Comparison of MRI pulse sequences in defining prostate volume after permanent implantationP W McLaughlin, V Narayana, D G Drake, et al.
Cancer Causes & Control : CCC|March 28, 2024
Guideline-concordant breast cancer care by patient race and ethnicity accounting for individual-, facility- and area-level characteristics: a SEER-Medicare studyEmma L Herbach, Michaela Curran, Mya L Roberson, et al.
Journal of Surgical Education|February 25, 2026
Grantsmanship Refined: Evaluation and Training of Efficacy in Residents (Greater Study)Rachael C Acker, Jeffrey L Roberson, John C McVey, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 regionBuck E Rogers, Peter L Roberson, Sui Shen, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 31, 2017
Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin LymphomaPeter L Roberson, Lauren B Smith, Meredith A Morgan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRIPatrick W McLaughlin, Vrinda Narayana, Amichay Meirovitz, et al.
American Journal of Preventive Medicine|September 1, 1995
Breast screening by African-American women: insights from a household survey and focus groupsN L Danigelis, N L Roberson, J K Worden, et al.
Pageof 21

Showing results (151-160 of 203) with videos related to

Sort By:
Pageof 21
Cancer Causes & Control : CCC|November 16, 2021
Validity of breast cancer surgery treatment information in a state-based cancer registryMya L Roberson, Hazel B Nichols, Stephanie B Wheeler, et al.
Journal of the National Cancer Institute|January 2, 2025
An intersectional analysis of behavioral financial hardship and healthcare utilization among lesbian, gay, bisexual, transgender, queer, plus cancer survivorsAustin R Waters, Stephanie B Wheeler, Jeremey Fine, et al.
Frontiers in Public Health|August 4, 2018
Engaging Black Churches to Address Cancer Health Disparities: Project CHURCHLorna H McNeill, Lorraine R Reitzel, Kamisha H Escoto, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2002
Comparison of MRI pulse sequences in defining prostate volume after permanent implantationP W McLaughlin, V Narayana, D G Drake, et al.
Cancer Causes & Control : CCC|March 28, 2024
Guideline-concordant breast cancer care by patient race and ethnicity accounting for individual-, facility- and area-level characteristics: a SEER-Medicare studyEmma L Herbach, Michaela Curran, Mya L Roberson, et al.
Journal of Surgical Education|February 25, 2026
Grantsmanship Refined: Evaluation and Training of Efficacy in Residents (Greater Study)Rachael C Acker, Jeffrey L Roberson, John C McVey, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 regionBuck E Rogers, Peter L Roberson, Sui Shen, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 31, 2017
Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin LymphomaPeter L Roberson, Lauren B Smith, Meredith A Morgan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRIPatrick W McLaughlin, Vrinda Narayana, Amichay Meirovitz, et al.
American Journal of Preventive Medicine|September 1, 1995
Breast screening by African-American women: insights from a household survey and focus groupsN L Danigelis, N L Roberson, J K Worden, et al.
Pageof 21